Leerink Partnrs Issues Negative Estimate for Zoetis Earnings

Key Points

• Leerink Partners has downgraded its Q3 2025 earnings estimate for Zoetis to $1.64 per share, down from $1.68, while maintaining a "Hold" rating on the stock.
• Institutional investors hold 92.80% of Zoetis' stock, indicating significant backing from large financial entities.
• Zoetis announced a quarterly dividend of $0.50, with an annual yield of 1.4%, to be paid on December 2nd, reflecting a consistent return to shareholders.

Zoetis Inc. (NYSE:ZTS - Free Report) - Leerink Partnrs lowered their Q3 2025 earnings per share estimates for Zoetis in a research report issued on Monday, October 13th. Leerink Partnrs analyst D. Clark now forecasts that the company will post earnings per share of $1.64 for the quarter, down from their prior estimate of $1.68. Leerink Partnrs has a "Hold" rating on the stock. The consensus estimate for Zoetis' current full-year earnings is $6.07 per share. Leerink Partnrs also issued estimates for Zoetis' Q4 2025 earnings at $1.44 EPS.

Several other analysts have also issued reports on ZTS. Leerink Partners lowered Zoetis from an "outperform" rating to a "market perform" rating and lowered their target price for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Stifel Nicolaus lowered Zoetis from a "buy" rating to a "hold" rating and lowered their target price for the company from $165.00 to $160.00 in a research note on Wednesday, June 18th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Zoetis in a research report on Wednesday, October 8th. Argus reiterated a "buy" rating and issued a $190.00 price target on shares of Zoetis in a research report on Tuesday, September 9th. Finally, Piper Sandler lifted their price target on Zoetis from $210.00 to $215.00 and gave the company an "overweight" rating in a research report on Monday, August 11th. Four equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $196.71.

Zoetis Stock Performance

Shares of ZTS opened at $142.29 on Tuesday. The firm has a market cap of $63.06 billion, a PE ratio of 24.49, a PEG ratio of 2.26 and a beta of 0.90. The stock's fifty day moving average price is $149.04 and its two-hundred day moving average price is $154.19. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. Zoetis has a 1 year low of $139.34 and a 1 year high of $196.55.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.14. The business had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis's quarterly revenue was up 4.2% compared to the same quarter last year. During the same period last year, the company posted $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS.

Institutional Investors Weigh In On Zoetis

A number of hedge funds and other institutional investors have recently modified their holdings of ZTS. Nova Wealth Management Inc. bought a new stake in shares of Zoetis in the 1st quarter valued at about $25,000. 1248 Management LLC bought a new position in Zoetis during the 1st quarter valued at approximately $27,000. Saudi Central Bank bought a new position in Zoetis during the 1st quarter valued at approximately $29,000. Cornerstone Planning Group LLC raised its position in Zoetis by 79.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock valued at $30,000 after purchasing an additional 88 shares during the last quarter. Finally, REAP Financial Group LLC raised its position in Zoetis by 201.5% during the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company's stock valued at $31,000 after purchasing an additional 131 shares during the last quarter. Institutional investors own 92.80% of the company's stock.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis's payout ratio is 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.